Shire to invest $400m for capacity expansion in Ireland

WCN Editorial Team 21 Apr 2016 EUROPE BUILDINGS

Biopharmaceutical company Shire has unveiled plans to expand its global biotechnology manufacturing capacity by investing $400m in Ireland.

The investment is planned to take place over the next four years to meet the growing demand for rare disease treatments.

Shire will create a new biologics manufacturing campus on a 120-acre site at Piercetown, County Meath. The facility will employ the latest bio-processing techniques and flexible production strategies to supply both clinical and commercial scale products.

About 700 jobs will be created during the construction phase. When operational, the facility will create 400 permanent jobs in the areas of research and development, operations, technical staff and engineering.

Shire’s senior vice president of technical operations Tim Kelly said: "The expansion supports our manufacturing strategy to develop and provide innovative specialty medicines for patients.

"Ireland is a strategically important location for Shire, providing both excellence in life science R&D and manufacturing. We already have a strong team on the ground in Ireland and believe that it is the right location for us to build a new state of the art facility which will complement our existing manufacturing operations in the US."

The project’s construction is expected to begin in mid-2016 with the site scheduled to be operational by mid-2019.

With 11 websites and newsletters covering all the key areas within the construction industry, World Construction Industry Network is the leading global construction information resource. READ ABOUT US



World Construction Network | is a product of GlobalData. Copyright © 2022 GlobalData. All rights reserved.